WBA sinks to a new low on Amazon industry threat

Reports that Amazon.com has received wholesale pharmaceutical licenses in 12 states has put pressure on the drug store sector today. WBA shares have been under pressure for about a month with channel support near $76.00 and $72.00 having failed already. The shares have approached $64.00 a potential measured support level with next measured move support possible near $56.00 should the initial test fail.